Eph/Ephrin Signaling in the Tumor Microenvironment.
ADAM
Angiogenesis
Breast cancer
Cancer stem cell
Colon cancer
Eph
Ephrin
Immune therapy
MAPK
Metastasis
PD-L1
Prognosis
Ras
RhoA
Tumor Progression
Journal
Advances in experimental medicine and biology
ISSN: 0065-2598
Titre abrégé: Adv Exp Med Biol
Pays: United States
ID NLM: 0121103
Informations de publication
Date de publication:
2021
2021
Historique:
entrez:
30
10
2020
pubmed:
31
10
2020
medline:
14
1
2021
Statut:
ppublish
Résumé
The Eph/ephrin system plays a vital role in diverse physiological events such as neurogenesis, vasculogenesis, and cell adhesion. Expression analysis of mRNA and protein in clinical samples revealed the involvement of the Eph/ephrin system in tumorigenesis, Alzheimer's disease, and atherosclerosis. Therefore, the Eph/ephrin system is considered a promising therapeutic target. However, no molecularly targeted drug against Ephs and ephrins is being used in the clinic thus far.Tumors are composed of various types of cells, including fibroblasts, immune cells, and endothelial cells. Recent studies showed the contribution of these cells to tumor growth, tumor progression, drug resistance, and metastasis. In this chapter, we discuss the role of Eph/ephrin system in the tumor microenvironment and describe its functions in tumor initiation, angiogenesis, cancer stem cell, tumor immunity, and also the metastatic environment.
Identifiants
pubmed: 33123992
doi: 10.1007/978-3-030-47189-7_3
doi:
Substances chimiques
Ephrins
0
Receptors, Eph Family
EC 2.7.10.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM